These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2553308)

  • 1. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie S; Maingay J; Neill WA
    Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative responses in recrudescent orofacial herpetic infections.
    Vestey JP; Norval M; Howie SE
    J R Soc Med; 1990 May; 83(5):308-11. PubMed ID: 2166159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie SE; Maingay JP; Neill W
    Br J Dermatol; 1990 Jan; 122(1):33-42. PubMed ID: 2153401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
    Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
    Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies of herpes simplex virus infection in children with atopic eczema.
    Goodyear HM; McLeish P; Randall S; Buchan A; Skinner GR; Winther M; Rolland J; Morgan G; Harper JI
    Br J Dermatol; 1996 Jan; 134(1):85-93. PubMed ID: 8745891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
    Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
    J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to herpes simplex virus in children receiving treatment for acute lymphoblastic leukaemia (ALL).
    Tellez PA; Odom L; Hayward AR
    Clin Exp Immunol; 1985 Dec; 62(3):525-9. PubMed ID: 3002690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
    McKenna DB; Neill WA; Norval M
    Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some immunological characteristics of subjects suffering from frequent herpes simplex virus recrudescences.
    Doutlík S; Kutinová L; Benda R; Kamínková J; Krcmár M; Votruba T; Suchánková A; Vonka V; Vacek Z
    Acta Virol; 1989 Sep; 33(5):435-46. PubMed ID: 2576584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological responses to herpes simplex virus type 1 (HSV-1) analysed with enzyme-linked immunosorbent assay (ELISA) and western blot (WB).
    Rabie-Finger H; Valentine-Thon E; Steinmann J; Nehrkorn A
    Acta Virol; 1991 Apr; 35(2):113-26. PubMed ID: 1681709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy.
    Ramaswamy M; Waters A; Smith C; Hainsworth E; Hardy G; Johnson M; Ainsworth J; Phillips A; Geretti AM
    J Infect Dis; 2007 Feb; 195(3):410-5. PubMed ID: 17205480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative and serological responses to herpes simplex virus during primary infection, recrudescence, and re-infection in a murine model.
    Maingay JP; Howie SE; Norval M; Moodycliffe AM; Neill WA
    Viral Immunol; 1989; 2(2):115-26. PubMed ID: 2789063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus.
    Hayward AR; Herberger MJ; Groothuis J; Levin MR
    J Immunol; 1984 Nov; 133(5):2469-73. PubMed ID: 6207230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limiting dilution analysis of specific in vitro anti-herpes simplex virus antibody production by human lymphocytes.
    Yasukawa M; Kobayashi Y
    Clin Exp Immunol; 1987 Apr; 68(1):39-47. PubMed ID: 2820632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
    Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
    Schrier RD; Ishioka GY; Pizer LI; Moorhead JW
    J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.